John S. Strader
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 3
-
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Peter M. Voorhees (7 shared papers)Robert Z. Orlowski (7 shared papers)Qing Chen (2 shared papers)Deborah J. Kuhn (4 shared papers)Congcong Sun (2 shared papers)Susan D. Demo (2 shared papers)Mark K. Bennett (2 shared papers)Kevin D. Shenk (2 shared papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
John S. Strader
7 papers receiving 715 citations
John S. Strader's Hit Papers
Peers
Comparison fields: 5 of 59
- Hematology 372
- Oncology 249
- Molecular Biology 551
- Genetics 47
- Cancer Research 42
Countries citing papers authored by John S. Strader
This map shows the geographic impact of John S. Strader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Strader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Strader more than expected).
Fields of papers citing papers by John S. Strader
This network shows the impact of papers produced by John S. Strader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Strader. The network helps show where John S. Strader may publish in the future.
Co-authors
The 25 scholars most cited alongside John S. Strader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma Hit paper breakdown → | 2007 | 615 |
| 2 | 2007 | 100 | |
| 3 | 2010 | 9 | |
| 4 | 2009 | 6 | |
| 5 | 2011 | 3 | |
| 6 | 2005 | 3 | |
| 7 | 2006 | 1 |
About John S. Strader
John S. Strader is a scholar working on Molecular Biology, Hematology, Oncology, Infectious Diseases and Organic Chemistry, having authored 7 papers that have together received 737 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Hematology (372 citations), Oncology (249 citations), Molecular Biology (551 citations), Genetics (47 citations) and Cancer Research (42 citations). John S. Strader has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Peter M. Voorhees, Robert Z. Orlowski, Qing Chen, Deborah J. Kuhn, Congcong Sun, Susan D. Demo, Mark K. Bennett, Kevin D. Shenk, Fijs W. B. van Leeuwen and Asher Chanan‐Khan. Their work appears in journals such as Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.